Le Lézard
Classified in: Science and technology
Subjects: CCA, FVT

CRITEO TO ANNOUNCE FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 7, 2024


NEW YORK, Jan. 24, 2024 /PRNewswire/ -- Criteo S.A. (NASDAQ: CRTO), the Commerce Media company, will announce its financial results for the fourth quarter and fiscal year ended December 31, 2023, on Wednesday, February 7, 2024.

On that day, Megan Clarken, Chief Executive Officer, and Sarah Glickman, Chief Financial Officer, will host a conference call at 8:00 AM ET, 2:00 PM CET to discuss these results. They will be joined by Todd Parsons, Chief Product Officer, for the Q&A session.

To access the conference call, please use the following dial-in numbers and ask to be joined into the "Criteo" call:

?   United States:             +1 855 209 8212
?   International:               +1 412 317 0788
?   France:                        080-510-2319

The conference call will be webcast live on the Company's website https://criteo.investorroom.com/ and will be available for replay.

About Criteo

Criteo (NASDAQ: CRTO) is the global commerce media company that enables marketers and media owners to drive better commerce outcomes. Its industry leading Commerce Media Platform connects thousands of marketers and media owners to deliver richer consumer experiences from product discovery to purchase. By powering trusted and impactful advertising, Criteo supports an open internet that encourages discovery, innovation, and choice. For more information, please visit www.criteo.com.

Contacts

Criteo Investor Relations
Melanie Dambre, [email protected]

Criteo Public Relations
Florian Herzing, [email protected]

SOURCE Criteo Corp


These press releases may also interest you

at 07:10
POSaBIT Systems Corporation (the "Company" or "POSaBIT") announces today that the Company is anticipating a delay in filing its annual financial statements and accompanying management's discussion and analysis for the year ended December 31, 2023...

at 07:06
Recently, at Auto China 2024, Neusoft Corporation (Neusoft, SSE:600718) launched OneCoreGo® Global In-Vehicle Intelligent Mobility Solutions 5.0, showcasing its innovative achievements in the AI+ Automotive field. It's also one of the series of...

at 07:05
Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based on defined bacterial consortia, today announced that members of its executive team will participate at the following investor...

at 07:05
Alentis Therapeutics ("Alentis"), a clinical-stage biotechnology company developing treatments for organ fibrosis and Claudin-1 positive tumors, announced today that Dr. Alberto Toso has been appointed as Chief Scientific Officer effective...

at 07:05
Deciphera Pharmaceuticals, Inc. , a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that it has entered into a definitive merger...

at 07:05
bit.bio, the company coding human cells for novel cures, and a pioneer in the field of synthetic biology, today announces it will participate in an engaging fireside chat at SynBioBeta 2024 featuring Nobel Laureate Thomas Südhof and bit.bio founder...



News published on and distributed by: